pharmaceutical investing BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer
pharmaceutical investing BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT
pharmaceutical investing BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT
pharmaceutical investing BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT
biotech investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
biotech investing BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+
biotech investing BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer
biotech investing BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
QIMC Reports Record 24.3% Clean Natural Hydrogen at Bennett Hill DDH-26-04 and Begins Technical Evaluation of Pilot-Scale Development Pathway and Clean Energy Generation
